These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3376790

  • 1. Growth inhibition by diethylstilbestrol and relapse of the Noble rat prostatic tumor.
    Wakisaka M, Drury RE, Kadohama N.
    Hinyokika Kiyo; 1988 Jan; 34(1):107-15. PubMed ID: 3376790
    [Abstract] [Full Text] [Related]

  • 2. Basal and estrogen-stimulated hormone receptor profiles in four R3327 rat prostatic carcinoma sublines in relation to histopathology and androgen sensitivity.
    Mobbs BG, Johnson IE.
    Cancer Res; 1988 Jun 01; 48(11):3077-83. PubMed ID: 3259159
    [Abstract] [Full Text] [Related]

  • 3. Effects of intermittent diethylstilbestrol diphosphate administration on the R3327 rat prostatic carcinoma.
    Russo P, Liguori G, Heston WD, Huryk R, Yang CR, Fair WR, Whitmore WF, Herr HW.
    Cancer Res; 1987 Nov 15; 47(22):5967-70. PubMed ID: 3664500
    [Abstract] [Full Text] [Related]

  • 4. Unusual androgen sensitivity of the androgen-independent Dunning R-3327-G rat prostatic adenocarcinoma: androgen effect on tumor cell loss.
    Humphries JE, Isaacs JT.
    Cancer Res; 1982 Aug 15; 42(8):3148-56. PubMed ID: 7093958
    [Abstract] [Full Text] [Related]

  • 5. Regulation of estrogen and progestin receptor concentrations in an experimental rat prostatic carcinoma by estrogen, antiestrogen, and progesterone.
    Mobbs BG, Johnson IE, DeSombre ER, Toth J, Hughes A.
    Cancer Res; 1987 May 15; 47(10):2645-51. PubMed ID: 3552202
    [Abstract] [Full Text] [Related]

  • 6. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE, Sholiton LJ, Srivastava LS, Knowles HC, Werk EE.
    J Clin Endocrinol Metab; 1976 Dec 15; 43(6):1226-33. PubMed ID: 1002814
    [Abstract] [Full Text] [Related]

  • 7. Hormone sensitivity of the R3327-G rat prostate adenocarcinoma: growth rate, DNA content, and hormone receptors.
    Pollack A, Irvin GL, Block NL, Lipton RM, Stover BJ, Claflin AJ.
    Cancer Res; 1982 Jun 15; 42(6):2184-90. PubMed ID: 7074599
    [Abstract] [Full Text] [Related]

  • 8. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor.
    Brass AL, Barnard J, Patai BL, Salvi D, Rukstalis DB.
    Cancer Res; 1995 Jul 15; 55(14):3197-203. PubMed ID: 7606741
    [Abstract] [Full Text] [Related]

  • 9. In vivo selection of androgen-insensitive cells in R3327-G rat prostate tumors: diethylstilbestrol diphosphate treatment versus orchiectomy.
    Pollack A, Block NL, Stover BJ, Irvin GL, Fuentes MP, Claflin AJ, Malinin TI.
    J Natl Cancer Inst; 1983 May 15; 70(5):907-14. PubMed ID: 6573535
    [Abstract] [Full Text] [Related]

  • 10. Suppression of androgen action and the induction of gross abnormalities of the reproductive tract in male rats treated neonatally with diethylstilbestrol.
    McKinnell C, Atanassova N, Williams K, Fisher JS, Walker M, Turner KJ, Saunders TK, Sharpe RM.
    J Androl; 2001 May 15; 22(2):323-38. PubMed ID: 11229807
    [Abstract] [Full Text] [Related]

  • 11. Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers.
    Letsch M, Schally AV, Szepeshazi K, Halmos G, Nagy A.
    Clin Cancer Res; 2003 Oct 01; 9(12):4505-13. PubMed ID: 14555524
    [Abstract] [Full Text] [Related]

  • 12. Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).
    George DJ, Dionne CA, Jani J, Angeles T, Murakata C, Lamb J, Isaacs JT.
    Cancer Res; 1999 May 15; 59(10):2395-401. PubMed ID: 10344749
    [Abstract] [Full Text] [Related]

  • 13. The relationship of androgen receptor levels to androgen responsiveness in the Dunning R3327 rat prostate tumor sublines.
    Diamond DA, Barrack ER.
    J Urol; 1984 Oct 15; 132(4):821-7. PubMed ID: 6471235
    [Abstract] [Full Text] [Related]

  • 14. Proliferative response of the Dunning R3327H experimental model of prostatic adenocarcinoma to conditions of androgen depletion and repletion.
    English HF, Kloszewski ED, Valentine EG, Santen RJ.
    Cancer Res; 1986 Feb 15; 46(2):839-44. PubMed ID: 3940646
    [Abstract] [Full Text] [Related]

  • 15. Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen.
    Gregory CW, Johnson RT, Mohler JL, French FS, Wilson EM.
    Cancer Res; 2001 Apr 01; 61(7):2892-8. PubMed ID: 11306464
    [Abstract] [Full Text] [Related]

  • 16. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER, Bujnovszky P, Walsh PC.
    Cancer Res; 1983 Mar 01; 43(3):1107-16. PubMed ID: 6186370
    [Abstract] [Full Text] [Related]

  • 17. C19-radiosteroid disposition in organ cultures of transplanted prostatic adenocarcinomas of the Noble rat.
    Ofner P, Leav I, Boucher WS, Vena RL.
    Cancer Res; 1987 Mar 15; 47(6):1701-5. PubMed ID: 3815367
    [Abstract] [Full Text] [Related]

  • 18. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma.
    Ip MM, Milholland RJ, Rosen F.
    Cancer Res; 1980 Jul 15; 40(7):2188-93. PubMed ID: 7388787
    [Abstract] [Full Text] [Related]

  • 19. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostatic cancer.
    Barrack ER, Tindall DJ.
    Prog Clin Biol Res; 1987 Jul 15; 239():155-87. PubMed ID: 3309954
    [No Abstract] [Full Text] [Related]

  • 20. Growth-stimulative effect of estrogen on androgen-dependent Shionogi carcinoma 115.
    Noguchi S, Kitamura Y, Uchida N, Yamaguchi K, Sato B, Matsumoto K.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5644-9. PubMed ID: 6498825
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.